Nitric oxide for cancer therapy

Research output: Contribution to journalReview articlepeer-review

53 Scopus citations


Resistance to current therapeutic interventions is a major challenge in the treatment of patients affected by cancer. While nitric oxide (NO) might have proneoplastic properties, it is now clear that at high doses, NO has a role in cancer therapeutics. Either as a single agent or in combination with other antineoplastic compounds, NO might be used to overcome tumor cell resistance to conventional treatments. The following discussion addresses the role of NO in cancer therapeutics and includes a report on the role of NO donors in the area of cancer therapeutics.

Original languageEnglish (US)
Article numberFSO44
JournalFuture Science OA
Issue number1
StatePublished - Aug 2015
Externally publishedYes


  • JSK
  • NO donors
  • NO hybrids
  • diazeniumdiolates

ASJC Scopus subject areas

  • Biotechnology


Dive into the research topics of 'Nitric oxide for cancer therapy'. Together they form a unique fingerprint.

Cite this